-KafilaOnline Blog On June 18 (Sunday evening in India), freedom-loving people across the world were shocked by the revelations of how a highly sophisticated and expensive digital technology, named Pegasus, a spyware sold by Israeli company NSO Group, has been systematically abused for years to spy on journalists, human rights defenders, academics, businesspeople, lawyers, doctors, union leaders, diplomats, politicians and even several heads of states. Regimes in several countries continue to...

Scientific knowledge has immensely helped in combating the dreadful coronavirus and its spread. Within a record short period of time, scientists (including virologists, epidemiologists, biostatisticians, etc.) and their research outputs helped the commoners to learn more about the SARS-CoV-2 and how it spreads from one individual to the next one. Common people have now come to know how simple techniques and behavioural change like the wearing of N95 masks, maintaining...

-The Hindu Gross domestic expenditure on research has stayed at 0.7% of the GDP for years While India has made ‘solid progress’ towards the Sustainable Development Goal (SDG) targets concerning industry, infrastructure and innovation, the country’s investment in research remains unsatisfactory, the UNESCO Science Report has observed. The gross domestic expenditure on research (GERD) has been stagnant at 0.7% of the GDP for years, although, in absolute terms, research expenditure has increased, the...

A recent report by the International Food Policy Research Institute (IFPRI) states that the countrywide lockdown imposed on 25th March, 2020, which was extended for nearly two months in phases, affected the food and nutritional status of vulnerable sections of the Indian population. It says that a programme like the Mid-Day Meal Scheme covers four-fifth of primary-school-aged children in the country that helps in improving not only nutrition but also...

-The Hindu Business Line It’s only an open-ended deal with co-developer Bharat Biotech, says top source The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract with co-developer Bharat Biotech is not close-ended. Currently, Bharat Biotech has the sole licence to manufacture Covaxin, which it developed in collaboration with scientists from ICMR’s Pune-based National Institute of Virology...